Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
UMC Utrecht
Memorial Sloan Kettering Cancer Center
Essen Biotech
Baylor College of Medicine
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
University of Nebraska
Medical College of Wisconsin
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
University of Arizona
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Washington University School of Medicine
University of Texas Southwestern Medical Center
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Cancer Research UK
The Netherlands Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Cancer Research UK
Arbeitsgemeinschaft medikamentoese Tumortherapie
Royal Marsden NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Stanford University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
City of Hope Medical Center
Cedars-Sinai Medical Center
Cancer Support Community, Research and Training Institute, Philadelphia
Zhejiang University
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Centre Georges Francois Leclerc
University of California, Davis
Emory University
Barbara Ann Karmanos Cancer Institute
University Hospital, Tours
Jules Bordet Institute
Memorial Sloan Kettering Cancer Center
Imperial College London
Augusta University
Assistance Publique - Hôpitaux de Paris
Shanghai Fengxian District Central Hospital
Hospices Civils de Lyon